Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION CONTAINING CBFβ-EXPRESSING VASCULAR SMOOTH MUSCLE CELLS OR CULTURE FLUID THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AGE-RELATED DISEASES
Document Type and Number:
WIPO Patent Application WO/2024/063484
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition containing Cbfβ (Core-binding factor subunit beta) expressing vascular smooth muscle cells or a culture fluid thereof as an active ingredient for the prevention or treatment of age-related diseases. It has been found that inhibition of Cbfβ expression in vascular smooth muscle cells promotes vascular calcification and osteoclast differentiation and that the culture fluid of Cbfβ-expressing vascular smooth muscle cells inhibits osteoclast differentiation. Thus, the composition can be advantageously utilized as a pharmaceutical composition for the prevention, treatment, alleviation, or diagnosis of age-related diseases.

Inventors:
CHOI JE-YONG (KR)
CHE XIANGGUO (KR)
JIN XIAN (KR)
Application Number:
PCT/KR2023/014083
Publication Date:
March 28, 2024
Filing Date:
September 18, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND (KR)
International Classes:
C12Q1/6883; C12N5/071; C12N5/078; C12N15/85
Domestic Patent References:
WO2021207655A12021-10-14
Foreign References:
KR102249135B12021-05-07
KR20210062959A2021-06-01
KR20220127749A2022-09-20
US20180282700A12018-10-04
Other References:
CHE XIANGGUO, JIN XIAN, PARK NA RAE, KIM HEE-JUNE, KYUNG HEE-SOO, KIM HYUN-JU, LIAN JANE B., STEIN JANET L., STEIN GARY S., CHOI J: "Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling", CELLS, vol. 12, no. 7, 1 April 2023 (2023-04-01), pages 1064, XP093149311, ISSN: 2073-4409, DOI: 10.3390/cells12071064
Attorney, Agent or Firm:
TAEBAEK INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: